Shares of Allurion Technologies, Inc. (ALUR) tumbled nearly 11% on Wednesday morning after the company’s fourth-quarter (Q4) ...

Chardan notes that Allurion has announced additional data evaluating the use of its Allurion Balloon in combination with patients be treated ...

Despite a dip in revenue, Allurion Technologies Inc (ALUR) showcases strategic advancements and a robust plan for future growth.

Reports Q4 revenue $5.6M, compared to $8.2M for the same period in 2023. The year-over-year decrease in revenue was primarily due to the ...

These patents, both of which are scheduled to issue on March 11, 2025, provide additional claims for an enhanced, next-generation version of Allurion’s proprietary Balloon technology for the ...

Microcap Allurion Technologies (NYSE:ALUR) surged ~31% in after-hours trading Thursday after posting preliminary data on weight loss associated with its gastric balloon in combination with Novo ...

Allurion Technologies (NYSE:ALUR – Get Free Report) is anticipated to release its earnings data before the market opens on ...

Forman, and Allurion Technologies are the five Small Cap stocks to watch today, according to MarketBeat’s stock screener tool. Small cap stocks represent shares of smaller companies, typically with ...

Second, the rapid weight loss achieved through the Allurion Balloon, the lifestyle modification strategies offered through the Allurion program and the remote monitoring through the Allurion ...

Hello, everyone, and welcome to Allurion fourth quarter earnings call. Please note that this call is being recorded. After the speaker's prepared remarks, there will be a question and answer session.